IP Library › Patent Application 18758176

Patent Application

App. No. 18/758,176

DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US None
App. No.: 18/758,176

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Disclosed herein are novel bifunctional compounds formed by conjugating BTK inhibitor moieties with E3 ligase Ligand moieties, which function to recruit targeted proteins to E3 ubiquitin ligase for degradation, and methods of preparation and uses thereof.

Claims (161)

1 . A compound of Formula (I):

or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof,

wherein:

the moiety is an E3 Ubiquitin ligase moiety selected from

Cy1a, Cy1b and Cy1c are each independently a 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-membered saturated ring or unsaturated ring comprising 0-3 heteroatoms selected from nitrogen, oxygen and sulfur as ring member(s);

Cy2 is a 5- or 6-membered saturated ring or unsaturated ring (preferably aromatic ring) comprising 0-3 heteroatoms selected from nitrogen, oxygen and sulfur as ring member(s);

Cy3 is a 5- or 6-membered saturated ring or unsaturated ring comprising no additional heteroatom;

L a , L b , L c and L d are each independently a single bond, —O—, —S—, —C(O)—, —(CR a R b ) n — or —NR c —;

L 1 and L 2 are each independently a single bond, —O—, —S—, —C(O)—, —(CR a R b ) n — or —NR c —;

Z 1 and Z 2 are each independently CH, CR 14 or N;

X e is each independently CR 14 or N;

each of occurrence, R 1 , R 2 , R 3 , R 4 , R 8 , R 9 , R 10 , R 11 , R 13 and R 14 are each independently hydrogen, halogen, —C 1-8 alkyl, —C 1-8 alkoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, oxo (═O), —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R e , —NR c R d , —NR c COR d , —NR c CONR d R c , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e , or —NR c SO 2 R d , each of said —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with halogen, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

R 6 , R 7 and R 12 are each independently hydrogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl, each of said —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with halogen, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

R 5 is 5- or 6-membered aromatic ring comprising 0-3 heteroatoms selected from nitrogen, oxygen and sulfur as ring member(s); said aromatic ring is optionally substituted with halogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, —C 1-8 alkoxy, cycloalkyl, heterocyclyl, aryl, heteroaryl, —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R e , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R c , —NR c SO 2 NR d R c , or —NR c SO 2 R d , each of said —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with —C 1-8 alkyl, halogen, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

p1, p2, p3, p4, p5 and p6 are each independently 0, 1, 2, 3 or 4;

s1, s2 and s3 are each independently 0, 1;

n is 0, 1, 2, 3, 4, 5 or 6;

R a and R b are each independently hydrogen, halogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, —C 1-8 alkoxy, cycloalkyl, heterocyclyl, aryl, heteroaryl, oxo (═O), —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R c , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R c , or —NR c SO 2 R d , each of said —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with halogen, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl; or

R a and R b together with the atom(s) to which they are attached, form a 3- to 12-membered ring, said ring comprising 0, 1 or 2 additional heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur as ring member(s), said ring is optionally substituted with at least one substituent independently selected from halogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, oxo, —CN or —NO 2 ;

R c , R d and R e are each independently hydrogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl; or

(R c and R d ) or (R d and R e ) together with the atom(s) to which they are attached, form a 3- to 12-membered ring, said ring comprising 0, 1 or 2 additional heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur as ring member(s), said ring is optionally substituted with at least one substituent independently selected from halogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, oxo, —CN or —NO 2 .

2 . The compound according to claim 1 , wherein the moiety is selected from

wherein

Cy3 is a 6-membered saturated ring or unsaturated ring comprising no additional heteroatom;

L 1 , X e , R 12 , R 13 and p6 are defined as in claim 1 .

3 . The compound according to claim 1 , wherein the moiety is selected from

L 1 , X e , R 12 , R 13 and p6 are defined as in claim 1 .

4 . The compound according to claim 1 , wherein the moiety is selected from

L 1 , L 2 , Z 1 , Z 2 , X e , R 12 , R 1 and p6 are defined as in claim 1 .

5 . The compound according to claim 1 , wherein the moiety is selected from

L 1 , L 2 , X e , R 12 , R 13 and p6 are defined as in claim 1 .

6 . The compound according to claim 1 , wherein

L 1 and L 2 are each independently a single bond, —O—, —S—, —C(O)—, —(CR a R b ) n — or —NR c —;

n is 1, 2, 3, 4, 5 or 6;

R a and R b are each independently hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl; or

R a and R b together with the atom(s) to which they are attached, form a 3-, 4-, 5-, 6-, 7- or 8-membered ring, said ring comprising 0, 1 or 2 additional heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur as ring member(s), said ring is optionally substituted with at least one substituent independently selected from halogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, oxo, —CN or —NO 2 ;

R c is each independently hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl.

7 . The compound according to claim 1 , wherein

p6 is each independently 0, 1, 2, 3 or 4;

X e is each independently CR 14 or N;

R 13 and R 14 are each independently hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C 2-8 alkenyl, —C 2-8 alkynyl, heterocyclyl, phenyl, heteroaryl, oxo (═O), —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R e , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e , or —NR c SO 2 R d ,

each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, —C 2-8 alkenyl, —C 2-8 alkynyl, heterocyclyl, phenyl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl;

R c , R d and R e are each independently hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl; or

(R c and R d ) or (R d and R e ) together with the atom(s) to which they are attached, form a 3-, 4-, 5-, 6-, 7- or 8-membered ring, said ring comprising 0, 1 or 2 additional heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur as ring member(s), said ring is optionally substituted with at least one substituent independently selected from halogen, —C 1-8 alkyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, oxo, —CN or —NO 2 ;

R 12 is each independently hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl, each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl.

8 . The compound according to claim 1 , wherein

L a , L b , L c and L d are each independently selected from a single bond, —O—, —CO—, —(CR a R b ) n — or —NR c —;

n is 1, 2, 3, 4 or 5;

R a and R b are each independently hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, oxo (═O), —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R c , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e or —NR c SO 2 R d ; each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl; or

R a and R b together with the atom(s) to which they are attached, form a 3-, 4-, 5-, 6-, 7- or 8-membered ring, said ring comprising 0, 1 or 2 additional heteroatoms independently selected from nitrogen, oxygen or optionally oxidized sulfur as ring member(s), said ring is optionally substituted with at least one substituent independently selected from F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, oxo, —CN or —NO 2 .

9 . The compound according to claim 1 , wherein

L a , L b , L c and L d are each independently selected from a single bond, —O—, —CO—, —(CR a R b ) n — or —NR c —;

n is 1, 2, 3, 4 or 5;

10 . The compound according to claim 1 , wherein L a , L b , L c and L d are each independently selected from a single bond, —O—, —CO—, —N(CH 3 )—, —NH—, —(CH 2 ) n —, —[CH(CH 3 )] n —, —[C(CH 3 ) 2 ] n —; n is 1, 2, 3, 4 or 5; preferably L a , L b , L c and L d are each independently selected from a single bond, —O—, —CO—, —N(CH 3 )—, —NH—, —CH 2 —, —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —.

11 . The compound of claim 1 , wherein Cy1a is each independently

each of

is optionally substituted with R 9 ,

n1, n2, n3, n4 and n5 are each independently 0, 1, 2, 3 or 4;

X 3 and X 4 are each independently selected from —CR a , or N;

X 5 , X 6 and X 7 are each independently selected from —NR c —, —O—, —S— and —CR a R b —;

R a , R b and R c are defined as in claim 1 ;

*1a refers to the position attached to the

moiety and **1a refers to the position attached to the

moiety.

12 . The compound of claim 1 , wherein Cy1a is each independently

is optionally substituted with R 9 ;

X 3 and X 4 are each independently selected from —CR a , or N;

X 5 , X 6 and X 7 are each independently selected from —NR c —, —O—, —S— and —CR a R b —;

R a and R b are each independently hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, oxo (═O), —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R c , —NR c R d , NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e or —NR c SO 2 R d ; each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl;

R c is independently selected from hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl.

13 . The compound of claim 1 , wherein Cy1a is each independently

14 . The compound of claim 1 , wherein Cy1b is each independently

each of

is optionally substituted with R 10 ,

n1, n2, n3, n4 and n5 are each independently 0, 1, 2, 3 or 4;

X 3 and X 4 are each independently selected from —CR a , or N;

X 5 , X 6 and X 7 are each independently selected from —NR c —, —O—, —S— and —CR a R b —;

R a , R b and R c are defined as in claim 1 ;

*1b refers to the position attached to the

moiety and **1b refers to the position attached to the

moiety.

15 . The compound of claim 1 , wherein Cy1b is each independently

is optionally substituted with R 10 ;

X 3 and X 4 are each independently selected from —CR a , or N;

X 5 , X 6 and X 7 are each independently selected from —NR c —, —O—, —S— and —CR a R b —;

16 . The compound of claim 1 , wherein Cy1b is each independently

17 . The compound of claim 1 , wherein Cy1c is each independently

each of

is optionally substituted with R 11 ,

n1, n2, n3, n4 and n5 are each independently 0, 1, 2, 3 or 4;

X 3 and X 4 are each independently selected from —CR a , or N;

X 5 , X 6 and X 7 are each independently selected from —NR c —, —O—, —S— and —CR a R b —;

R a , R b and R c are defined as in claim 1 ;

*1c refers to the position attached to the

moiety and **1c refers to the position attached to the

moiety.

18 . The compound of claim 1 , wherein Cy1c is each independently

each of

is optionally substituted with R 11 ;

X 3 and X 4 are each independently selected from —CR a , or N;

X 5 , X 6 and X 7 are each independently selected from —NR c —, —O—, —S— and —CR a R b —;

R a and R b are each independently hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, oxo (═O), —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R e , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e or —NR c SO 2 R d ; each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl;

19 . The compound of claim 1 , wherein Cy1c is each independently

20 . The compound of claim 1 , wherein the

moiety is

wherein *La refers to the position attached to the

moiety and *Lb refers to the position attached to the

moiety.

21 . The compound of claim 1 , wherein

R 1 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R c , —NR c R d , —NR c COR d , —NR c CONR d R c , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e , or —NR c SO 2 R d , each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, -methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl;

22 . The compound of claim 1 , wherein R 1 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN or —NO 2 ; preferably R 1 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, cyclopropyl, cyclobutyl.

23 . The compound of claim 1 , wherein

R 2 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R e , —NR c R d , —NR c COR d , —NR c CONR d R c , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e , or —NR c SO 2 R d , each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, -methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl;

24 . The compound of claim 1 , wherein R 2 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN or —NO 2 ; preferably R 2 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, butoxy, cyclopropyl, cyclobutyl, cyclopentyl, —CN or —NO 2 .

25 . The compound of claim 1 , wherein

R 3 and R 4 are each independently hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R e , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R c , —NR c SO 2 NR d R e , or —NR c SO 2 R d , each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, -methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl;

26 . The compound of claim 1 , wherein R 3 and R 4 are each independently hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl or —CN; preferably R 3 and R 4 are each independently hydrogen, methyl, ethyl, propyl, butyl, cyclopropyl, cyclobutyl or cyclopentyl.

27 . The compound of claim 1 , wherein the

moiety is

wherein *3 refers to the position attached to the

moiety, and **3 refers to the position attached to

moiety.

28 . The compound of claim 1 , wherein R 6 and R 7 are each independently hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl, each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl; preferably, R 6 and R 7 are each independently H, methyl, ethyl, propyl butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.

29 . The compound of claim 1 , wherein R 5 is

Y 1 , Y 2 , Y 3 and Y 4 are each independently selected from CH, O, S or N; R 15 is each independently selected from hydrogen, halogen, —C 1-8 alkyl, —C 1-8 alkoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R c , —NR c R d , —NR c COR d , —NR c CONR d R e , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e , or —NR c SO 2 R d , each of said —C 1-8 alkyl, —C 1-8 alkoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with halogen, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl; R c , R d , and R c are each independently defined as in claim 1 ; and p7 is 0, 1, 2, 3 or 4.

30 . The compound of claim 29 , wherein Y 1 is CH, S, N or O; Y 2 is CH, S, O or N; Y 3 is CH, O, S or N; and Y 4 is CH, O, S or N.

31 . The compound of claim 28 , wherein

is selected from

32 . The compound according to claim 29 , wherein, R 15 is selected from —H, —F, —Cl, —Br, —I, —CH 3 , —C 2 H 5 , —C 3 H 7 , —C 4 H 9 , —C 5 H 11 , —C 6 H 13 , methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, —C 2-8 alkenyl, —C 2-8 alkynyl, —CH 2 OH, —CH 2 CH 2 OH, —CH(OH)CH 3 , —CH 2 CH 2 CH 2 OH, —CH(OH)CH 2 CH 3 , —CH 2 CH(OH)CH 3 , —CH 2 OCH 3 , —CFH 2 , —CF 2 H, —CF 3 , —CH 2 CF 3 , —CH 2 CH 2 CF 3 , each of said —CH 3 , —C 2 H 5 , —C 3 H 7 , —C 4 H 9 , —C 5 H 11 , —C 6 H 13 , methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, —C 2-8 alkenyl, —C 2-8 alkynyl is optionally substituted with at least one F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, —C 1-8 alkyoxy, cycloalkyl, heterocyclyl, aryl, or heteroaryl.

33 . The compound according to claim 29 , wherein, R 15 is selected from

34 . The compound of claim 1 , wherein the

moiety is

35 . The compound of claim 1 , wherein Cy2 is a 5- or 6-membered aromatic ring comprising 0-3 heteroatoms selected from nitrogen, oxygen and sulfur as ring member(s).

36 . The compound of claim 1 , wherein

Y 1 , Y 2 , Y 3 and Y 4 are each independently defined as in claim 1 ;

wherein *Cy2 refers to the position attached to the

moiety, and **3 refers to the position attached to

moiety.

37 . The compound of claim 1 , wherein

38 . The compound of claim 1 , wherein

R 8 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN, —NO 2 , —OR c , —SO 2 R c , —COR c , —CO 2 R c , —CONR c R d , —C(═NR c )NR d R c , —NR c R d , —NR c COR d , —NR c CONR d R c , —NR c CO 2 R d , —NR c SONR d R e , —NR c SO 2 NR d R e , or —NR c SO 2 R d , each of said methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl or heteroaryl is optionally substituted with F, Cl, Br, I, hydroxy, -haloC 1-8 alkyl, -methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, or heteroaryl;

39 . The compound of claim 1 , wherein R 8 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, hexoxy, hepthoxy, octoxy, —C 2-8 alkenyl, —C 2-8 alkynyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, heterocyclyl, aryl, heteroaryl, —CN or —NO 2 ; preferably R2 is hydrogen, F, Cl, Br, I, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, butoxy, cyclopropyl, cyclobutyl, cyclopentyl, —CN or —NO 2 .

40 . The compound of claim 1 , wherein

41 . The compound of claim 1 , wherein the

moiety is selected from

42 . The compound of claim 1 , wherein the compound is selected from

43 . A pharmaceutical composition comprising the compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier or excipient.

44 . A method of inhibiting BTK activity, which comprises administering to an individual the compound according to claim 1 , or a pharmaceutically acceptable salt thereof, including the compound of formula (I) or the specific compounds exemplified herein.

45 . A method of treating a disease or disorder in a patient comprising administering to the patient in need thereof a therapeutically effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt thereof as a BTK kinase inhibitor, wherein the disease or disorder is associated with inhibition of BTK, preferably, the disease or disorder is cancer.

Assignments (5)

CHANGE OF NAME Recorded Sep 23, 2025

From: BEIGENE SWITZERLAND GMBH

To: BEONE MEDICINES I GMBH

Reel/Frame 072872/0076 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2024

From: HUO, CHANGXIN; WANG, HEXIANG; QI, RUIPENG; WANG, ZHIWEI; LIU, HUAQING

To: BEIGENE, LTD.

Reel/Frame 069204/0719 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2024

From: BEIGENE, LTD.

To: BEIGENE SWITZERLAND GMBH